FindTrial
Sign In

Sedation with dexmedetomidine and targeted controlled infused remifentanil for pediatric fiberoptic intubation

Sedation with dexmedetomidine and targeted controlled infused remifentanil for pediatric fiberoptic intubation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015786
Enrollment
Unknown
Registered
2018-04-20
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric airway management

Interventions

observational group:dexmedetomidine and remifentanil (EC50)
observational group:dexmedetomidine and remifentanil (EC95)
controlled group:dexmedetomidine+normal saline

Sponsors

Plastic Surgery Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: the patients aged 5-12 years old, planed to under going general anesthesia with tracheal intubation will be included

Exclusion criteria

Exclusion criteria: Obesity (BMI=30kg/m2), difficult airway, atrioventricular block II or III, be allergic to dexmedetomidine or remifentanil, asthma, neuropsychological disease.

Design outcomes

Primary

MeasureTime frame
successful incidence of intubation;successful incidence of intubation;incidence of repiratory inhibition;incidence of upper respiratory obstruction;—

Countries

China

Contacts

Public ContactWei Lingxin

Plastic Surgery Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

weilx3934@sina.com+86 13621159500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026